Clinical trial • Phase III • Oncology|Gastroenterology
Clinical trial in Metastatic colorectal cancer
Phase III trial for Metastatic colorectal cancer. 25 participants.
Overview
- Trial Therapeutic Area
- Oncology|Gastroenterology
- Trial Disease
- Metastatic colorectal cancer
- Trial Stage
- Phase III
- Drug Modality
- Radiopharmaceutical|Diagnostic agent
Key dates
- Initial CTIS Submission Date
- 23-04-2024
- First CTIS Authorization Date
- 19-08-2024
Trial design
Phase III trial across 1 site in Netherlands.
- Target Sample Size
- 25
Recruitment
- Planned Sample Size
- 25
- Recruitment Window Months
- 36
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 25
Netherlands
- Earliest CTIS Part Ii Submission Date
- 07-07-2024
- Latest Decision Or Authorization Date
- 03-03-2026
- Processing Time Days
- 604
- Number Of Sites
- 1
- Number Of Participants
- 25
Sites
- Site Name
- Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
- Department Name
- Nuclear Medicine
- Principal Investigator Name
- Marnix Lam
- Principal Investigator Email
- m.lam@umcutrecht.nl
- Contact Person Name
- Marnix Lam
- Contact Person Email
- m.lam@umcutrecht.nl
- Number Of Participants
- 25
Sponsor
Primary sponsor
- Full Name
- Universitair Medisch Centrum Utrecht
- Organisation Type
- Hospital/Clinic/Other health care facility
- Country Of Registered Address
- Netherlands
Related trials
Other published trials that may interest you.